A response to ‘Nanotechnology and the need for risk governance’, O. Renn & M.C. Roco, 2006. J. Nanoparticle Research 8(2): 153–191
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (7)
Show source-provided references
1. Borm P, Klaessig FC, Landry TD, Moudgil B, Pauluhn J, Thomas K, Trottier R, Wood S (2006) Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles. Toxicol Sci 90(1):23–3210.1093/toxsci/kfj084 ↗
2. Health Council of the Netherlands (2006) Health significance of nanotechnologies. The Hague: Health Council of the Netherlands; publication no. 2006/06E; www.healthcouncil.nl
3. Nel A, Xia T, Mädler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311:622–62710.1126/science.1114397 ↗
4. Renn O (2005) White paper on risk governance; towards an integrative approach. White paper no. 1. Geneva: International Risk Governance Council; www.irgc.org
5. Renn O, Roco MC (2006a) Nanotechnology and the need for risk governance. J Nanopart Res 8(2):153–19110.1007/s11051-006-9092-7 ↗
6. Renn O, Roco MC (2006b) White paper on nanotechnology risk governance. White paper no. 2. Geneva: International Risk Governance Council; www.irgc.org
7. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) (2005) Opinion on the appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies. Brussels: European Commission, Health & Consumer Protection Directorate-General, Directorate C—Public Health and Risk Assessment